Journal of Clinical Investigation APC and Open Access: Society Publishing With a Price Tag to Match
JCI charges $5,800 for a gold open access Research article ($5,600 for ASCI members). No subscription track. ASCI costs, waivers, and funder compliance.
Readiness scan
APC budgeted? See what Journal of Clinical Investigation reviewers are likely to push back on.
The fee is one decision. Getting through review is the harder one. Run the Free Readiness Scan with Journal of Clinical Investigation as your target to see desk-rejection risk, likely reviewer concerns, and journal fit.
Journal of Clinical Investigation publishing costs and open access options
APC is one cost. Funder mandates, institutional agreements, and access route timing all shape what you actually pay.
What shapes what you pay
- Journal of Clinical Investigation offers open access publishing. Check whether your institution has a read-and-publish agreement.
- Funder mandates (NIH, Wellcome, UKRI) may require immediate OA, verify compliance before choosing a subscription route.
- Check the journal's correspondence for any access-route deadline; an APC does not establish when that choice is due.
When OA is worth the cost
- When your funder or institution requires it, non-compliance can affect future funding.
- When your topic benefits from broad immediate access beyond institutional subscribers.
- Open access can widen practical access, but it does not change whether the journal fits the manuscript.
Quick answer: Founded in 1924, the Journal of Clinical Investigation is one of those rare journals that has spent a full century building its reputation without the backing of a commercial publishing conglomerate. It's published by the American Society for Clinical Investigation, a physician-scientist society, and that ownership structure shapes everything about its cost model.
If you're looking up the JCI APC, the short answer is: $5,800 for a Research or Clinical Research and Public Health article from non-ASCI members ($5,600 for ASCI members, $5,400 for YPSA/EGen awardees), $2,500 for a Research Letter, and $0 for a Letter to the Editor. JCI has no subscription route; all content is open access.
What JCI charges for publication
JCI is a gold open access journal: since the January 4, 2022 issue all content is freely available, and accepted Research, Clinical Research and Public Health, and Research Letter articles are assessed a publication fee:
Component | Amount (USD) |
|---|---|
Research or Clinical Research and Public Health APC, non-ASCI members | $5,800 |
Same, ASCI members in good standing | $5,600 |
Same, YPSA/EGen awardees | $5,400 |
Research Letter APC (non-ASCI / ASCI / YPSA-EGen) | $2,500 / $2,400 / $2,250 |
Letter to the Editor | $0 |
JCI Insight gold OA (Research, non-ASCI members) | $5,000 |
Submission fee | $0 |
The fee depends on the submission category and on membership status (the ASCI member must be the responsible party/corresponding author). Authors receive an invoice with the publication proof, and JCI's fee table lists no separate page or color-figure charges.
Compared to commercial publishers charging $10,000+ for prestige titles, JCI's APC is moderate. That's a direct result of society ownership. ASCI isn't extracting profit margins for shareholders. The APC covers production costs, digital infrastructure, and the editorial office.
If the cost looks workable, the harder question is whether your paper will clear desk review. A Journal of Clinical Investigation desk-rejection risk check takes about 2 to 3 minutes before you commit to these fees.
No subscription track: all content is open access
JCI has no subscription track. Effective with the January 4, 2022 issue, JCI is a Gold Open Access journal in which all content is freely available without charge to the user or their institution, and authors retain copyright under a Creative Commons Attribution License (CC BY 4.0).
There is no charge to submit, and JCI's fee table lists only the publication fee. JCI is indexed in PubMed/Medline, Scopus, and Web of Science, among others.
JCI deposits published research articles in PubMed Central, and articles published with a CC BY license are freely available there on the publication date, without embargo.
JCI Insight: the open access sister journal
JCI Insight is the gold open access companion to JCI, published by the same society. Every article in JCI Insight is immediately free to read.
The APC for JCI Insight is $5,000 for a Research, Clinical Research and Public Health, or Resource and Technical Advance article from non-ASCI members, $800 less than JCI's $5,800 fee for a Research article. JCI Insight has a broader scope than JCI. It publishes clinical and translational research that may be more specialized or incremental than what the flagship accepts.
Key differences between the two:
Feature | JCI | JCI Insight |
|---|---|---|
Model | Gold OA | Gold OA |
APC | $5,800 (Research, non-ASCI) | $5,000 (Research, non-ASCI) |
IF (2025) | 13.3 | 6.0 |
PubMed Central | Deposited; CC BY articles free on publication date, no embargo | Deposited |
Article types | Research, Clinical Research and Public Health, Research Letter, Letter to the Editor | Research, Clinical Research and Public Health, Resource and Technical Advance, Research Letter, Physician-Scientist Development |
If your paper doesn't land at JCI, JCI Insight editors may screen it and invite you to transfer. When a paper is transferred after peer review, the JCI reviews go with it, and Dual-Journal Submission routes reviewed papers to JCI Insight with the existing reviews.
Institutional agreements and coverage
JCI's fee pages do not describe institutional or Read & Publish agreements. They do say that requests for publication fee discounts are considered on a case-by-case basis. Outside support depends on your funder and institution:
- Funder and grant budgets: Check whether your funder or grant budget allows publication fees before you submit.
- Individual university OA funds: Many research universities maintain open access funds that reimburse APCs for their faculty; check your library's limits against JCI's $5,800 fee.
Check your library's open access funding page before assuming you'll pay out of pocket.
Waivers and discounts
JCI's fee table includes lower fees for some authors, and discounts are considered case by case:
Member and awardee rates: An ASCI member in good standing who is the responsible party/corresponding author pays $5,600 instead of $5,800 for a Research or Clinical Research and Public Health article ($2,400 instead of $2,500 for a Research Letter). ASCI Council Young Physician-Scientist Award (YPSA) and Emerging-Generation Award (EGen) awardees pay $5,400 and $2,250 in those categories.
Discounts on request: JCI says requests for publication fee discounts are considered on a case-by-case basis.
Letters to the Editor: The Letter to the Editor category has a $0 fee.
Funder mandate compliance
JCI's open access model meets the funder requirements it lists:
Funder/Policy | Compliant? | Route |
|---|---|---|
Plan S (cOAlition S) | Yes | JCI says it meets cOAlition S requirements; all articles are CC BY 4.0 |
NIH Public Access Policy | Yes | JCI deposits published research articles in PubMed Central |
UKRI | Yes | JCI says it is fully compliant with UKRI open access policies |
Wellcome Trust | Yes | JCI says it is fully compliant with Wellcome open access policies |
HHMI | Yes | JCI says it is fully compliant with HHMI open access policies |
JCI deposits published research articles in PubMed Central on authors' behalf, and says this satisfies the NIH Public Access Policy and similar funder requirements. Authors do not need to submit their accepted articles to PubMed Central separately.
For Plan S compliance, no extra choice is needed: all JCI articles since the January 4, 2022 issue are published under CC BY 4.0, and authors retain copyright. If your funder has special license requirements, JCI asks you to list them during submission.
How JCI compares to peer journals
Journal | APC (USD) | Model | IF (2025) | Green OA Embargo |
|---|---|---|---|---|
JCI | $5,800 (Research, non-ASCI) | Gold OA | 14.3 | None; PMC deposit, CC BY free on publication date |
Journal of Experimental Medicine | $5,450 (OA) / $0 | Hybrid | 11.6 | 6 months |
Nature Medicine | $12,290 | Hybrid | 52.3 | 6 months |
Cell Reports Medicine | $5,790 | Gold OA | 14 | N/A |
PNAS | $6,075 (publisher price, October 2026) | Hybrid | 9.5 | Varies by option |
JCI sits in the same price band as the Journal of Experimental Medicine, which makes sense. Both are society-owned, biomedical, and have similar impact factors. Nature Medicine is in a different price universe entirely, but it also has a dramatically higher impact factor.
Cell Reports Medicine is an interesting comparison. It's gold OA only at $5,790, which is almost the same as JCI's $5,800 fee for a Research article. JCI's Letter to the Editor category is the only JCI category with a $0 fee.
PNAS costs less only through its delayed open access route ($3,025; immediate open access is $6,075), and it has a lower JIF. For translational and clinical research specifically, JCI carries more weight in the biomedical community than PNAS does.
Readiness check
Run the scan while the topic is in front of you.
See score, top issues, and journal-fit signals before you submit.
Hidden costs and things to watch
JCI's fee table is simple: there is no charge to submit, and the table lists no page or color-figure charges. But there are a few things to be aware of:
- License: Articles are published under CC BY 4.0 and authors retain copyright. If your funder has special license requirements, list them during submission.
- Data deposition: JCI requires that large gene expression, high-throughput sequencing, and proteomics data sets be deposited in public repositories (GEO for genomics, ClinicalTrials.gov for trial registration). The repositories themselves are free, but preparing data for deposition takes time.
- Figure revision costs: If JCI staff find that your figures do not meet Journal guidelines, they may request revised figures, which could delay the decision on a manuscript. JCI's fee table lists no charge for figure rework.
Green OA and self-archiving
JCI's self-archiving and preprint policies are permissive:
- JCI says authors are permitted to post the final published version of the manuscript in institutional repositories.
- JCI deposits published research articles in PMC automatically, and CC BY articles are freely available there on the publication date.
- JCI says authors are permitted to post manuscripts on bioRxiv and medRxiv, and it does not consider research manuscripts posted to a community preprint server to be prior publications.
This combination of no embargo plus automatic PMC deposit plus a permissive preprint policy makes JCI author-friendly on access issues.
The practical decision
For clinical and translational researchers, JCI remains one of the top-tier targets. The cost decision is straightforward:
- NIH-funded, no Plan S requirement? JCI deposits published research articles in PMC for you, which JCI says satisfies the NIH Public Access Policy. Budget for the publication fee.
- Plan S funder (Wellcome, UKRI)? JCI says it meets cOAlition S requirements and is fully compliant with Wellcome and UKRI policies. Budget $5,800 for a Research article (non-ASCI members) and check your institution's OA fund.
- Paper not quite JCI level? JCI Insight is a strong fallback at a lower APC ($5,000 for a Research article), from the same society.
Getting into JCI is the hard part. JCI's journal metrics page reports a 9.5% accept rate (June 2025 to May 2026), and the editors look for translational significance that connects basic findings to clinical outcomes. Before you submit, make sure your manuscript meets that bar. You can Journal of Clinical Investigation submission readiness check to identify gaps that might trigger a desk rejection at this level.
For more on how open access costs vary across the biomedical landscape, see our guide to Nature's APC or the full journal publishing fees overview.
Is open access at Journal of Clinical Investigation worth the APC?
Worth paying if:
- Your funder mandates open access (check Plan S / cOAlition S requirements)
- An institutional Read & Publish agreement covers the fee
- Open access visibility meaningfully benefits your research area
- The APC fits within your grant budget
Consider alternatives if:
- The APC is a personal out-of-pocket expense
- Your funder accepts green OA (preprint posting), which would mean a different journal, because JCI publishes everything as gold open access
- Another OA journal with a lower APC would provide similar visibility
For a manuscript-specific signal before you submit, run a JCI submission readiness check.
Or see example reports before you finalize.
Frequently asked questions
JCI is a gold open access journal and charges a publication fee (APC) after acceptance. For a Research or Clinical Research and Public Health article the fee is $5,800 for non-ASCI members, $5,600 for ASCI members in good standing, and $5,400 for YPSA/EGen awardees; a Research Letter is $2,500, $2,400, or $2,250; a Letter to the Editor is $0. There is no charge to submit, and authors receive an invoice with the publication proof.
Only in the Letter to the Editor category, which has a $0 fee. JCI has been gold open access since the January 4, 2022 issue, so there is no subscription route, and Research, Clinical Research and Public Health, and Research Letter articles carry a fee. JCI says requests for publication fee discounts are considered on a case-by-case basis.
Yes. JCI says it meets cOAlition S requirements for authors funded by Plan S signatories and is fully compliant with HHMI, Wellcome, and UKRI open access policies. Articles are published under a CC BY 4.0 license, and JCI deposits published research articles in PubMed Central, where CC BY articles are freely available on the publication date without embargo.
JCI Insight is the sister journal published by the same society, with a lower APC ($5,000 against $5,800 for a Research article from non-ASCI members) and a broader scope. Both journals are gold OA. Both are published by ASCI and have independent editorial boards, but JCI has a higher impact factor (around 13.3 vs 6.0 for JCI Insight).
JCI does not publish a waiver program on its fee pages. It says requests for publication fee discounts are considered on a case-by-case basis, and its fee table gives lower fees to ASCI members in good standing (the ASCI member must be the responsible party/corresponding author) and to YPSA/EGen awardees.
Sources
- JCI - Author Guidelines
- JCI - Open access and publication fee
- JCI - Journal Homepage
- Clarivate Journal Citation Reports (2026 release for the 2025 Journal Impact Factor)
Free guide
The list price is rarely the price you pay.
Waivers, funder agreements and institutional deals move it, and the deadline for most of them is submission, after which there is no appeal. Every figure in the guide was read off the publisher or funder page that sets it, on the date shown, and each one is linked at the end.
Before you upload
Want the full picture on Journal of Clinical Investigation?
Scope, selectivity, what editors want, common rejection reasons, and submission context, all in one place.
These pages attract evaluation intent more than upload-ready intent.
Private API processing. Your manuscript is not used to train models.
Put the guidance to work
Build a journal decision from more than one signal.
Use comparison data as a starting point, then confirm the live source that governs the actual submission decision.
Where to go next
Same journal, next question
- Journal of Clinical Investigation Submission Guide: What to Prepare Before You Submit
- Is Journal of Clinical Investigation a Good Journal? A Practical Fit Verdict for Authors
- JCI Impact Factor 2026: 14.3 | The Gold Standard for Translational Medicine
- JCI Acceptance Rate 2026: How Selective Is the Gold Standard?
- JCI Review Time: What to Expect From Submission to Decision
- JCI Cover Letter: What Editors Actually Need to See